Results 121 to 130 of about 4,520 (170)
Some of the next articles are maybe not open access.
AJN, American Journal of Nursing, 2022
According to this study: In a phase 2/phase 3 study of Paxlovid use in patients at standard risk for developing severe COVID-19, the primary end point of self-reported sustained alleviation of all symptoms for four consecutive days wasn't met.A nonsignificant ...
openaire +2 more sources
According to this study: In a phase 2/phase 3 study of Paxlovid use in patients at standard risk for developing severe COVID-19, the primary end point of self-reported sustained alleviation of all symptoms for four consecutive days wasn't met.A nonsignificant ...
openaire +2 more sources
Effectiveness of Paxlovid - a review
2023Abstract Paxlovid is an oral treatment for mild to moderate COVID-19 cases with a high risk for severe course of the disease. For this review, we have performed a comprehensive literature review. We present a summary of currently available data on Paxlovid’s ability to reduce the risk of progressing to a severe disease state.
Sydney Paltra, Tim Conrad
openaire +1 more source
Optimizing the use of Paxlovid in clinical practice
Drugs of Today, 2022On December 22, 2021, the United States Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for nirmatrelvir/ritonavir (Paxlovid) for the treatment of mild to moderate coronavirus disease 2019 (COVID-19). The drug is authorized for use in patients 12 years of age and older weighing at least 40 kg who have tested positive for ...
openaire +2 more sources
Paxlovid as a potential treatment for long COVID
Expert Opinion on Pharmacotherapy, 2023On 31 July 2023, the United States Department of Health and Human Services announced the formation of the Office of Long COVID Research and Practice and the United States National Institutes of Health opened enrollment for RECOVER-Vital, a randomized study to evaluate new treatment options for long Coronavirus (long COVID).The RECOVER Initiative is a ...
openaire +2 more sources
American Journal of Respiratory and Critical Care Medicine
Abstract Introduction:Hyponatremia, defined as serum sodium levels <135 mEq/L, is one of the most common electrolyte abnormality among hospitalized patients, with Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) as a frequent cause. The diagnosis can be challenging due to its complex pathophysiology and multiple
S. Goyal, V. Vedantam
openaire +1 more source
Abstract Introduction:Hyponatremia, defined as serum sodium levels <135 mEq/L, is one of the most common electrolyte abnormality among hospitalized patients, with Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) as a frequent cause. The diagnosis can be challenging due to its complex pathophysiology and multiple
S. Goyal, V. Vedantam
openaire +1 more source